It’s Never Too Soon: How and When to Engage Medical Affairs
Engagement with Medical Affairs is critical at every juncture in the drug development process, with Medical Affairs acting as a key liaison between internal stakeholders, a new generation of physicians, and patient advocates...
Read MoreTop Stories
It’s Never Too Soon: How and When to
Engagement with Medical Affairs is critical at every...
Celebrating Health Literacy Month 2024:
October is Health Literacy Month, a reminder of the...
Celebrating World Patient Safety Day 2024:
On World Patient Safety Day 2024, we focus on the critical...
Filter
What Makes Stakeholders Trust Pharma-Generated Scientific Content and How Can the Industry Do Better?
While diverse pharma stakeholders are now consuming scientific content digitally more than ever before, the...
Effectiveness of Artificial Intelligence-Powered Translation Tools in Developing Medical Publications: An Assessment of Japanese-to-English Translation
Artificial intelligence (AI)–powered translation tools are gaining attention and acceptance to increase efficiency in medical...
The Evolution of Medical Communications: How to Get the Most Out of Standard Response Documents
Better patient awareness has led to a rapid increase in the number of MI requests...
Ways Pharma Showed Patients How They Matter
Patient centricity is transforming the life sciences industry today. Here are outstanding examples of how...
From Transactional to Transformational: Bringing Patient Centricity to the Next Level
The pharma industry’s focus is shifting from the transactional approach to a transformational approach by...
Why Do Plain Language Clinical Trial Summaries Matter?
Did you know that the European Medicines Agency’s Clinical Trials Regulation comes into effect on...